| abstract |
Disclosed herein are novel compounds of formula (I) as described herein, and the use of such peptides in the production of immunoconjugates (ie, antibody drug conjugates). Also described herein are immunoconjugates comprising such novel compounds linked to an antigen binding moiety such as an antibody (ie, antibody drug conjugates), wherein such immunoconjugates are cell proliferative. Useful for the treatment of disorders. The present invention relates to pharmaceutical compositions comprising these immunoconjugates, compositions comprising immunoconjugates and therapeutic coagents, and methods of using these immunoconjugates and compositions for treating cell proliferative disorders. Further provide. |